U.S. Clinical Nutrition Market Size By Product [Infant Nutrition (Milk Based, Soy Based, Organic), Parenteral Nutrition (Amino Acids, Fats, Carbohydrates), Enteral Nutrition (Standard Composition, Disease Specific Composition)], By Consumer (Child, Adult), Application Potential, Competitive Market Share & Forecast, 2020 – 2026

Published Date: Jan 2020  |  Report ID: GMI4514  |  Authors: Sumant Ugalmugle, Rupali Swain

Report Format: PDF   |   Pages: 80   |   Base Year: 2019




Summary Table of Contents Industry Coverage Methodology

Industry Trends

U.S. Clinical Nutrition Market Size valued over USD 11.2 billion in 2019 and is anticipated to grow at over 7.1% CAGR during 2020 to 2026. Growing awareness regarding the clinical nutrition among the patients has surged the market demand for nutritional products among the pediatric as well as adult population.
 

U.S. Clinical Nutrition Market

Get more details on this report - Request Free Sample PDF

 

Increase in geriatric population, growing prevalence of chronic diseases and unhealthy food habits have resulted in augmenting the market growth. The number of people that suffer from enfeebling conditions require nutritional supply through several routes that include enteral and parenteral route of clinical nutrition. These factors will contribute to market expansion over the analysis timeframe.
 

Increasing number of preterm and new births across the country will further propel the U.S. clinical nutrition industry growth. The market players are emphasizing on strategic expansion through several inorganic strategies such as, mergers, acquisition, strategic collaboration and new product launches to gain significant market share and to strengthen their product portfolio. Industry players are also focusing on development of nutritional solutions that can fulfil the nutritional needs of all the paediatric and adult population. Hence, the above-mentioned factors will enhance the market demand in the future.
 

U.S. Clinical Nutrition Market Report Coverage
Report Coverage Details
Base Year: 2019 Market Size in 2019: 11,291.1 Million (USD)
Historical Data for: 2015 to 2019 Forecast Period: 2020 to 2026
Forecast Period 2020 to 2026 CAGR: 7.1% 2026 Value Projection: 18,251.6 Million (USD)
Pages: 80 Tables, Charts & Figures: 42
Geographies covered (1): U.S.
Segments covered: Product and Consumer
Companies covered (9): Abbott Laboratories, B. Braun, Baxter, Danone, Fresenius Kabi, Hospira, Mead Johnson, Nestle and Perrigo
Growth Drivers:
  • Increasing metabolic disorders and other chronic diseases
  • Junk food habits leading to malnourishment in U.S.
  • Rising geriatric population
  • Increasing rate of pre-mature birth & birth rate in U.S.
  • Increasing adoption of home healthcare in U.S.
Pitfalls & Challenges:
  • Stringent government regulations in U.S.

Request 15% Free Customization on this Report
 

Rising number of patients suffering from chronic disorders and growing old age population will boost the adoption of clinical nutrition products across the globe

U.S. Clinical Nutrition Market

Get more details on this report - Request Free Sample PDF
 

Growing obese population owing to unhealthy eating habits along with limited physical activities will propel the U.S. clinical nutrition industry growth. According to the CDC data, more than 35% of the American children are known to consume junk food on daily basis resulting in conditions such as obesity, diabetes and cardiovascular diseases. Many of the old age people are suffering from digestive problems and loss of appetite and require sufficient supply of nutrients either enterally or parenterally route. Hence, the fuelling market growth.
 

Malnourishment is one of the major problem that is observed in pre-mature babies. Growing number of pre-mature births in the country will drive the market growth over the estimation period. As per the World Health Organisation (WHO) 2017 data, in U.S., around 0.5 million pre-term babies are born every year. However stringent regulations related to clinical nutrition products along with lack of awareness about clinical nutrition in some the regions in country will impede the U.S. clinical nutrition market growth over the coming years.
 

Rising incidence of chronic diseases will spur the demand for enteral nutrition
 

By product the clinical nutrition market is segmented into infant, parenteral, and enteral clinical nutrition. The enteral nutrition segment held 32% market share in 2019 and is expected to witness substantial growth. Enteral segment includes standard and disease specific composition for enteral clinical nutrition. Rising incidence of chronic diseases such as cancer and diabetes which require enteral feeding will positively impact the market demand. Additionally, rising rates of obesity will augment the product demand. These factors will fuel the U.S. clinical nutrition market growth over the forecast period.
 

Infant nutrition segment held market value of USD 6.2 billion in 2019. It is expected that the segment will witness robust growth over the analysis period. The rise in number of premature births will augment the market growth. According to World Health Organization (WHO) the U.S. was one of the high-risk countries for premature childbirth and had approximately 0.5 million preterm births in 2017. It is estimated that this number will continue to increase. This will boost the infant clinical nutrition segment, spurring the market expansion. Furthermore, increasing disposable income will contribute to the market growth.
 

Rise in number of working mothers will boost the child nutrition segment
 

The child nutrition market segment will exhibit 7.6% CAGR over the forecast timeframe. The high growth can be attributed to the rise in number of working mothers and their increased reliance on formulated clinical nutrition products. Furthermore, rising awareness pertaining to importance of nutrition during the formative years of a child will boost the market demand for clinical nutrition products, boosting the industry expansion.
 

Adult nutrition segment was valued around USD 4.8 billion in 2019 and will witness substantial growth. The rising preference for home healthcare will propel the segment growth. Increasing patient preference for therapy in the comfort of their home due to the elimination of a lengthy commute will increase the market demand for adult clinical nutrition. Furthermore, rising geriatric population in the country will contribute to raising the demand for clinical nutrition products. These factors will positively impact the industry growth.
 

Execution of strategies such as partnerships and collaborations by major industry players will boost the market growth
 

Some significant players in U.S. clinical nutrition market share are Fresenius Kabi, Nestle, Abbott Laboratories, B Braun, Danone, Hospira, Mead Johnson, Baxter and Perrigo. Merger and acquisition, strategic alliances and geographical expansion strategies are major strategies adopted by industry players to consolidate their market position in the U.S. clinical nutrition space.
 

Recent industry developments:
 

  • In August 2019, Nestle acquired Persona. Persona is a market leader in the personal nutrition segment and offers personalized nutrition products as well as supplements such as vitamins and amino acids. This move will help Nestle in increasing their customer base and revenue generation from the clinical nutrition space.
     
  • In January 2017, Nestle expanded their product portfolio in the clinical nutrition space with the launch of Compleat, a feeding formula catering to adult and children. This move has assisted the company in increasing their market share in the clinical nutrition industry.
     

The U.S. clinical nutrition market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2015 to 2026, for the following segments:
 

By Product

  • Infant nutrition
    • Milk Based
    • Soy Based
    • Organic
    • Others
  • Parenteral nutrition
    • Amino Acids
    • Fats
    • Carbohydrates
    • Others
  • Enteral nutrition
    • Standard composition
    • Disease specific composition

By Consumer

  • Child
  • Adult

 

Frequently Asked Questions (FAQ) :

The enteral nutrition segment held 32% market share in 2019 and is expected to witness substantial growth, says a GMI report.
The child nutrition segment in U.S. will exhibit 7.6% CAGR over the forecast timeframe.
According to this report, infant nutrition segment held a valuation of USD 6.2 billion in 2019.
Some of the significant players in the industry include Fresenius Kabi, Nestle, Abbott Laboratories, B Braun, Danone, Hospira, Mead Johnson, Baxter and Perrigo.

Buy Now

Single User: $2,850 Access to only 1 person; cannot be shared; cannot be printed
Multi User: $4,850 Access for 2 to 5 users only within same department of one company
Enterprise User: $6,850 Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Need a Discount? Get in touch with us for special pricing

Request Discount

Connect with our sales team

Why Global Market Insights, Inc.?

Reliability & accuracy

  • GMI is unparalleled when to comes to the quality of research and information provided to clients. Our unique methodology is designed to ensure a minimum of 90% accuracy to give our clients excellent value on their investment.

Quality & trust


  • BBB Rating - Click to Verify

Customer service

  • Over 200 experts are available across various time-zones, ready to serve clients for their research needs. Our industry experts help clients to design reports customized to their needs.

Security & compliance

GMIPulse Subscription

An interactive business analytics platform; designed to assist clients in accessing and analyzing market data on real-time basis.

Start Your Free Trial
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X